Moreover, the increased production of IL-18 and IL-1β mediated by inflammasomes contributes to the onset and progression of RA, type II diabetes, and various neurodegenerative disorders, including Alzheimer’s disease (AD) and ALS51. This evidence concerns the gene IL1B and type 2 diabetes mellitus.